These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 23262938

  • 1. Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
    Park JY, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DS, Nam JH.
    Obstet Gynecol; 2013 Jan; 121(1):136-42. PubMed ID: 23262938
    [Abstract] [Full Text] [Related]

  • 2. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin.
    Simpson AN, Feigenberg T, Clarke BA, Gien LT, Ismiil N, Laframboise S, Massey C, Ferguson SE.
    Gynecol Oncol; 2014 May; 133(2):229-33. PubMed ID: 24561246
    [Abstract] [Full Text] [Related]

  • 3. Conservative treatment with progestin and pregnancy outcomes in endometrial cancer.
    Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, Lim JY, Kwon YS, Lee IH, Lim KT, Lee KH, Shim JU, Mok JE, Kim TJ.
    Int J Gynecol Cancer; 2009 Aug; 19(6):1068-73. PubMed ID: 19820370
    [Abstract] [Full Text] [Related]

  • 4. Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
    Park JY, Kim DY, Kim JH, Kim YM, Kim KR, Kim YT, Seong SJ, Kim TJ, Kim JW, Kim SM, Bae DS, Nam JH.
    Eur J Cancer; 2013 Mar; 49(4):868-74. PubMed ID: 23072814
    [Abstract] [Full Text] [Related]

  • 5. Hormonal therapy for women with stage IA endometrial cancer of all grades.
    Park JY, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH.
    Obstet Gynecol; 2013 Jul; 122(1):7-14. PubMed ID: 23743459
    [Abstract] [Full Text] [Related]

  • 6. Pregnancy and oncologic outcomes after fertility-sparing management for early stage endometrioid endometrial cancer.
    Chae SH, Shim SH, Lee SJ, Lee JY, Kim SN, Kang SB.
    Int J Gynecol Cancer; 2019 Jan; 29(1):77-85. PubMed ID: 30640687
    [Abstract] [Full Text] [Related]

  • 7. Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
    Park JY, Lee SH, Seong SJ, Kim DY, Kim TJ, Kim JW, Kim JH, Kim YM, Kim YT, Bae DS, Nam JH.
    Gynecol Oncol; 2013 Apr; 129(1):7-11. PubMed ID: 23283299
    [Abstract] [Full Text] [Related]

  • 8. [Pregnant rate and pregnancy-relating factors of patients with early endometrial carcinoma and severe atypical hyperplasia of endometrium after fertility-preserving treatment by progestin].
    Cao DY, Yu M, Yang JX, Shen K, Huang HF, Cheng NH, Sun ZY, Deng CY, Yu Q, He FF.
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):519-22. PubMed ID: 24284224
    [Abstract] [Full Text] [Related]

  • 9. Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia.
    Fan Y, Li X, Wang J, Wang Y, Tian L, Wang J.
    Reprod Biol Endocrinol; 2021 Aug 03; 19(1):118. PubMed ID: 34344384
    [Abstract] [Full Text] [Related]

  • 10. The role of prolonged progestin treatment and factors predicting successful fertility-sparing treatment for early endometrial endometrioid adenocarcinoma.
    Ou YC, Fu HC, Lan J, Wu CH, Kung FT, Lan KC, Tsai YC, Lin H.
    Eur J Obstet Gynecol Reprod Biol; 2021 Dec 03; 267():99-104. PubMed ID: 34739876
    [Abstract] [Full Text] [Related]

  • 11. Continued medical treatment for persistent early endometrial cancer in young women.
    Cho A, Lee SW, Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT.
    Gynecol Oncol; 2021 Feb 03; 160(2):413-417. PubMed ID: 33246662
    [Abstract] [Full Text] [Related]

  • 12. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
    Mao Y, Wan X, Chen Y, Lv W, Xie X.
    Fertil Steril; 2010 Jan 03; 93(1):283-5. PubMed ID: 19962142
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of high-dose progestin and long-term outcomes in young women with early-stage, well-differentiated endometrioid adenocarcinoma of uterine endometrium.
    Park H, Seok JM, Yoon BS, Seong SJ, Kim JY, Shim JY, Park CT.
    Arch Gynecol Obstet; 2012 Feb 03; 285(2):473-8. PubMed ID: 21706284
    [Abstract] [Full Text] [Related]

  • 14. Oncologic and reproductive outcomes after fertility-sparing management with oral progestin for women with complex endometrial hyperplasia and endometrial cancer.
    Chen M, Jin Y, Li Y, Bi Y, Shan Y, Pan L.
    Int J Gynaecol Obstet; 2016 Jan 03; 132(1):34-8. PubMed ID: 26493012
    [Abstract] [Full Text] [Related]

  • 15. Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?
    Greenwald ZR, Huang LN, Wissing MD, Franco EL, Gotlieb WH.
    Cancer; 2017 May 01; 123(9):1545-1554. PubMed ID: 28026855
    [Abstract] [Full Text] [Related]

  • 16. Significance of body weight change during fertility-sparing progestin therapy in young women with early endometrial cancer.
    Park JY, Seong SJ, Kim TJ, Kim JW, Bae DS, Nam JH.
    Gynecol Oncol; 2017 Jul 01; 146(1):39-43. PubMed ID: 28526167
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate.
    Nomura H, Sugiyama Y, Tanigawa T, Matoda M, Kanao H, Kondo E, Takeshima N.
    Arch Gynecol Obstet; 2016 Jan 01; 293(1):177-181. PubMed ID: 26209972
    [Abstract] [Full Text] [Related]

  • 18. Efficacies and pregnant outcomes of fertility-sparing treatment with medroxyprogesterone acetate for endometrioid adenocarcinoma and complex atypical hyperplasia: our experience and a review of the literature.
    Ohyagi-Hara C, Sawada K, Aki I, Mabuchi S, Kobayashi E, Ueda Y, Yoshino K, Fujita M, Tsutsui T, Kimura T.
    Arch Gynecol Obstet; 2015 Jan 01; 291(1):151-7. PubMed ID: 25118836
    [Abstract] [Full Text] [Related]

  • 19. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G, Falcone F, Scaffa C, Messalli EM, Del Giudice M, Losito S, Greggi S.
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec 01; 195():61-66. PubMed ID: 26476800
    [Abstract] [Full Text] [Related]

  • 20. Fertility-sparing therapy for young women with endometrial cancer.
    Frumovitz M, Gershenson DM.
    Expert Rev Anticancer Ther; 2006 Jan 01; 6(1):27-32. PubMed ID: 16375641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.